Global Next-Generation Sequencing eDNA Biomonitoring Market Growth (Status and Outlook) 2024-2030

The global Next-Generation Sequencing eDNA Biomonitoring market size is predicted to grow from US$ 23.3 million in 2024 to US$ 37.8 million in 2030; it is expected to grow at a CAGR of 8.4% from 2024 to 2030.

Next-generation sequencing technology, also known as high-throughput sequencing technology or new generation sequencing technology, can split DNA samples into thousands of tiny fragments, and quickly read them through high-throughput sequencers, and finally splice out a complete DNA sequence. This technology has the advantages of high throughput, low cost and short sequencing cycle, and shows extremely high detection accuracy and sensitivity in genome sequencing and genome monitoring.

High-throughput sequencing technology (i.e., next-generation sequencing technology) has the advantages of high throughput, low cost, and short sequencing cycle, and shows extremely high detection accuracy and sensitivity in genome sequencing and genome monitoring. These technological advances have made DNA biomonitoring more efficient and accurate, thereby driving the growth of the market. On the other hand, with the development of bioinformatics, the ability to analyze and interpret sequencing data is also constantly improving. This helps to extract valuable information from massive sequencing data and provide more accurate data support for environmental monitoring, disease diagnosis, etc.

With the continuous improvement of people's awareness of environmental protection, the demand for monitoring environmental DNA (eDNA) is also increasing. By monitoring DNA in the environment, we can understand the health of the ecosystem and promptly detect and respond to potential ecological problems. In the medical field, DNA sequencing technology is also widely used in disease diagnosis and prevention. By sequencing and analyzing individual genomes, the risk of individual illness can be predicted, providing strong support for early prevention and treatment of diseases. This demand has also driven the development of the next-generation sequencing environmental DNA biomonitoring market.

Although next-generation sequencing technology has made significant progress, there are still some technical challenges and limitations. For example, the accuracy and sensitivity of sequencing need to be further improved to better meet the needs of environmental monitoring and disease diagnosis. The amount of data generated by sequencing is huge, and contains a lot of redundant and erroneous information. How to extract valuable information from massive data is a technical problem currently faced. In addition, data analysis also requires professional knowledge and skills, which increases the complexity and cost of the operation.

In addition, although the cost of next-generation sequencing technology has been greatly reduced, it is still a considerable expense for some small laboratories or research institutions. The high cost of sequencing limits the widespread application and promotion of the technology.

Although the next-generation sequencing environmental DNA biomonitoring technology has broad application prospects, the current market awareness of it is not high. Some potential customers may take a wait-and-see attitude towards this new technology, waiting for it to further mature and popularize. Customers in different fields and industries have different acceptance of technology. Some fields may prefer to adopt traditional monitoring methods and technologies, and are less willing to try new sequencing technologies.

ReportPrime's newest research report, the “Next-Generation Sequencing eDNA Biomonitoring Industry Forecast” looks at past sales and reviews total world Next-Generation Sequencing eDNA Biomonitoring sales in 2023, providing a comprehensive analysis by region and market sector of projected Next-Generation Sequencing eDNA Biomonitoring sales for 2024 through 2030. With Next-Generation Sequencing eDNA Biomonitoring sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Next-Generation Sequencing eDNA Biomonitoring industry.

This Insight Report provides a comprehensive analysis of the global Next-Generation Sequencing eDNA Biomonitoring landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Next-Generation Sequencing eDNA Biomonitoring portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Next-Generation Sequencing eDNA Biomonitoring market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Next-Generation Sequencing eDNA Biomonitoring and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Next-Generation Sequencing eDNA Biomonitoring.

This report presents a comprehensive overview, market shares, and growth opportunities of Next-Generation Sequencing eDNA Biomonitoring market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Targeted Sequencing & Resequencing
• Whole Genome Sequencing
• Whole Exome Sequencing

Segmentation by Application:

• Water
• Soil
• Air
• Others

Market by Region:

• Americas
• APAC
• Europe
• Middle East & Africa

Company Coverage:

• Illumina, Inc
• Stantec
• Eurofins Genomics
• Spygen
• ID-Gene Ecordiagnostics
• EnviroDNA
• eDNAtec
• Genidaqs
• NatureMetrics
• Jonah Ventures
• Sinsoma GmbH
• SimplexDNA

Key Questions Addressed in this Report: